EyePoint Pharmaceuticals Announces Renowned Scientists to Join New Executive Scientific Advisory Board

NEXT STORY
Myriad Genetics Expands Access to Genetic Testing with Launch of First Polygenic Breast Cancer Risk Assessment Score Validated for Women of All Ancestries
PREV STORY
OKYO Pharma Limited Announces final audited results for the year ended 31 March 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global microRNA Markets Report 2021-2028 – High Investments in miRNA R&D Initiatives for Development of New Diagnostic Tests & Therapeutics

author_avatar
NASDAQ Market News

Argos Therapeutics Announces Publication of a Case Report on Long-term Survival of Kidney Cancer Patients Treated with AGS-003 Individualized Immunotherapy Featured in the Kidney Cancer Journal

Two advanced kidney cancer patients from a Phase 2 clinical trial maintain ongoing control ...

author_avatar
NASDAQ Market News

ACR Webinar: Reproductive Health & Rheumatic Disease

author_avatar
NASDAQ Market News